Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Share News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
390.00    0.00 (0.00%)
Bid:
385.00
Ask:
395.00
Spread: 10.00 (2.597%)
Market Cap: £187.19m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Tristel flags forecast-busting full-year results

Mon, 22nd Jul 2024 09:11

(Sharecast News) - Infection prevention products manufacturer Tristel released a robust trading update for the year ended 30 June on Monday, with revenues and pre-tax profits surpassing market expectations.

The AIM-traded company recorded a 16.4% increase in full-year revenue, reaching £41.9m, compared to £36m in 2023.

That growth exceeded Tristel's performance target of an annual average revenue growth of 10% to 15% over three years.

The company's adjusted profit before tax was anticipated to be no less than £8.0 million, representing a 29% increase from the prior year's £6.2 million and also exceeding market expectations.

Tristel said it remained debt-free and continued to generate cash, with cash balances rising to £11.6m as of 30 June, up from £9.5m a year earlier.

The firm's strong financial performance was put down to robust demand for Tristel's infection prevention products across all its geographical markets, including the United States and Canada.

"This is my last trading update before I hand over the reins to our incoming CEO in early September and I am delighted to report to shareholders that the business has delivered another strong trading performance and growth ahead of both analyst expectations and our own growth targets," said chief executive officer Paul Swinney.

"This is an exciting transition point for our Company as I pass the CEO baton on to Matt Sassone.

"Tristel has become a leading global player in a specific niche of the global infection prevention industry: the decontamination of non-lumened heat sensitive medical devices."

Swinney said that niche "sweeps up" many of the diagnostic tools used in hospitals ranging from ultrasound probes to small endoscopes.

"Looking to the future, we are confident that we will also become a leading player in the hospital surface disinfection market with our unique chlorine dioxide chemistry.

"We are all very excited for the company's future prospects."

At 0912 BST, shares in Tristel were up 6% at 477p.

Reporting by Josh White for Sharecast.com.

Related News

IN BRIEF: Tristel names Christopher Lee as next chief executive
17 Jun 2026

IN BRIEF: Tristel names Christopher Lee as next chief executive

Tristel PLC - Newmarket, England-based maker of infection prevention products - Appoints Christopher Lee as chief executive officer with effect from A...

Tristel appoints Christopher Lee as its new CEO
17 Jun 2026

Tristel appoints Christopher Lee as its new CEO

(Sharecast News) - Tristel announced the appointment of Christopher Lee as its chief executive officer on Wednesday, effective 1 August, following a c...

LONDON BROKER RATINGS: UBS raises BP; Berenberg cuts Antofagasta
16 Apr 2026

LONDON BROKER RATINGS: UBS raises BP; Berenberg cuts Antofagasta

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Tristel News

IN BRIEF: Tristel names Christopher Lee as next chief executive
17 Jun 2026

IN BRIEF: Tristel names Christopher Lee as next chief executive

Tristel PLC - Newmarket, England-based maker of infection prevention products - Appoints Christopher Lee as chief executive officer with effect from A...

Tristel appoints Christopher Lee as its new CEO
17 Jun 2026

Tristel appoints Christopher Lee as its new CEO

(Sharecast News) - Tristel announced the appointment of Christopher Lee as its chief executive officer on Wednesday, effective 1 August, following a c...

LONDON BROKER RATINGS: UBS raises BP; Berenberg cuts Antofagasta
16 Apr 2026

LONDON BROKER RATINGS: UBS raises BP; Berenberg cuts Antofagasta

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

EARNINGS AND TRADING: Gelion loss narrows; Brave Bison in System1 deal
2 Mar 2026

EARNINGS AND TRADING: Gelion loss narrows; Brave Bison in System1 deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...

Tristel reports double-digit revenue growth, higher profitability
2 Mar 2026

Tristel reports double-digit revenue growth, higher profitability

(Sharecast News) - Tristel reported double-digit revenue growth and higher profitability for its first half on Monday, supported by strong momentum in...